Sol Schulman, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thromboplastin | 4 | 2023 | 291 | 2.160 |
Why?
|
von Willebrand Diseases | 2 | 2023 | 127 | 0.950 |
Why?
|
von Willebrand Disease, Type 2 | 1 | 2023 | 8 | 0.940 |
Why?
|
Hemostatics | 1 | 2023 | 229 | 0.760 |
Why?
|
Blood Coagulation Disorders, Inherited | 1 | 2020 | 18 | 0.760 |
Why?
|
Factor VIIa | 1 | 2021 | 101 | 0.730 |
Why?
|
Hemophilia A | 1 | 2023 | 351 | 0.730 |
Why?
|
Thrombosis | 4 | 2023 | 2968 | 0.650 |
Why?
|
Frameshift Mutation | 1 | 2020 | 399 | 0.650 |
Why?
|
Rodenticides | 1 | 2014 | 21 | 0.510 |
Why?
|
Protein Disulfide-Isomerases | 2 | 2015 | 198 | 0.490 |
Why?
|
Vitamin K | 1 | 2014 | 295 | 0.420 |
Why?
|
Mixed Function Oxygenases | 2 | 2010 | 272 | 0.420 |
Why?
|
Blood Coagulation Disorders | 1 | 2014 | 337 | 0.400 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2012 | 142 | 0.380 |
Why?
|
Thioredoxins | 1 | 2010 | 213 | 0.330 |
Why?
|
Hemorrhage | 3 | 2016 | 3461 | 0.330 |
Why?
|
Endoplasmic Reticulum | 2 | 2011 | 1144 | 0.300 |
Why?
|
Genome-Wide Association Study | 1 | 2023 | 12261 | 0.240 |
Why?
|
Erythrocytes | 1 | 2012 | 2455 | 0.220 |
Why?
|
Phospholipid Transfer Proteins | 1 | 2023 | 91 | 0.210 |
Why?
|
Phosphatidylserines | 1 | 2023 | 193 | 0.210 |
Why?
|
Factor VIII | 1 | 2023 | 347 | 0.200 |
Why?
|
Peptide Chain Termination, Translational | 1 | 2020 | 28 | 0.190 |
Why?
|
Hemostasis | 1 | 2023 | 458 | 0.190 |
Why?
|
Anticoagulants | 2 | 2014 | 4599 | 0.180 |
Why?
|
Neutrophils | 1 | 2012 | 3719 | 0.180 |
Why?
|
von Willebrand Factor | 1 | 2023 | 669 | 0.170 |
Why?
|
Phospholipids | 1 | 2023 | 784 | 0.170 |
Why?
|
Codon, Nonsense | 1 | 2020 | 281 | 0.170 |
Why?
|
Haploinsufficiency | 1 | 2020 | 328 | 0.160 |
Why?
|
Mice, Knockout | 3 | 2023 | 14557 | 0.160 |
Why?
|
Thrombocytopenia | 2 | 2016 | 1179 | 0.150 |
Why?
|
Oxidation-Reduction | 2 | 2015 | 2187 | 0.150 |
Why?
|
Receptor, TIE-2 | 1 | 2018 | 178 | 0.150 |
Why?
|
Cardiovascular Diseases | 1 | 2023 | 15165 | 0.150 |
Why?
|
Disseminated Intravascular Coagulation | 1 | 2018 | 188 | 0.150 |
Why?
|
Serine | 1 | 2021 | 826 | 0.150 |
Why?
|
Blood Platelet Disorders | 1 | 2016 | 58 | 0.130 |
Why?
|
Integrin beta3 | 1 | 2015 | 122 | 0.130 |
Why?
|
Thrombelastography | 1 | 2017 | 164 | 0.130 |
Why?
|
Quantitative Trait Loci | 1 | 2023 | 2019 | 0.130 |
Why?
|
Blood Platelets | 2 | 2023 | 2508 | 0.120 |
Why?
|
Heterozygote | 1 | 2020 | 2804 | 0.120 |
Why?
|
Primary Myelofibrosis | 1 | 2016 | 215 | 0.120 |
Why?
|
Monocytes | 1 | 2023 | 2596 | 0.110 |
Why?
|
src-Family Kinases | 1 | 2016 | 551 | 0.110 |
Why?
|
Rosette Formation | 1 | 2012 | 153 | 0.110 |
Why?
|
COS Cells | 2 | 2016 | 1161 | 0.110 |
Why?
|
Electron Transport | 2 | 2010 | 211 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2015 | 578 | 0.100 |
Why?
|
Gene Amplification | 1 | 2015 | 1063 | 0.100 |
Why?
|
Catalytic Domain | 2 | 2010 | 698 | 0.100 |
Why?
|
Synechocystis | 1 | 2010 | 10 | 0.100 |
Why?
|
Structural Homology, Protein | 1 | 2010 | 91 | 0.090 |
Why?
|
Endothelial Cells | 1 | 2023 | 3479 | 0.090 |
Why?
|
Synechococcus | 1 | 2010 | 28 | 0.090 |
Why?
|
Alternative Splicing | 1 | 2015 | 1117 | 0.090 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2020 | 1736 | 0.080 |
Why?
|
Base Sequence | 1 | 2020 | 12797 | 0.080 |
Why?
|
Mutation | 5 | 2016 | 29786 | 0.080 |
Why?
|
Animals | 8 | 2023 | 168757 | 0.080 |
Why?
|
Hearing Loss | 1 | 2016 | 765 | 0.080 |
Why?
|
Bacterial Proteins | 4 | 2010 | 3848 | 0.080 |
Why?
|
Methanococcus | 1 | 2007 | 10 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 3 | 2023 | 15519 | 0.080 |
Why?
|
Coronary Artery Bypass | 1 | 2017 | 2289 | 0.070 |
Why?
|
Humans | 17 | 2023 | 744343 | 0.070 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2010 | 1723 | 0.070 |
Why?
|
Mice | 3 | 2023 | 81183 | 0.070 |
Why?
|
Hedgehog Proteins | 1 | 2011 | 783 | 0.070 |
Why?
|
Species Specificity | 1 | 2010 | 2478 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2023 | 5256 | 0.070 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13102 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 2018 | 4456 | 0.070 |
Why?
|
Phenotype | 2 | 2020 | 16365 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2016 | 2916 | 0.060 |
Why?
|
Bone and Bones | 1 | 2016 | 2575 | 0.060 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2023 | 5221 | 0.060 |
Why?
|
Sepsis | 1 | 2018 | 2593 | 0.060 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3597 | 0.060 |
Why?
|
Protein Binding | 1 | 2015 | 9386 | 0.060 |
Why?
|
Recombinant Proteins | 2 | 2010 | 6622 | 0.060 |
Why?
|
Female | 8 | 2023 | 380194 | 0.050 |
Why?
|
Mice, Inbred C57BL | 1 | 2020 | 21827 | 0.050 |
Why?
|
Endoribonucleases | 1 | 2023 | 229 | 0.050 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18029 | 0.050 |
Why?
|
Unfolded Protein Response | 1 | 2023 | 233 | 0.050 |
Why?
|
Membrane Transport Proteins | 1 | 2007 | 1028 | 0.050 |
Why?
|
Cell Membrane | 2 | 2007 | 3748 | 0.050 |
Why?
|
Escherichia coli Proteins | 1 | 2007 | 1050 | 0.050 |
Why?
|
Aged | 4 | 2023 | 163280 | 0.040 |
Why?
|
Models, Molecular | 1 | 2010 | 5456 | 0.040 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2023 | 581 | 0.040 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5535 | 0.040 |
Why?
|
Pedigree | 2 | 2016 | 4644 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2015 | 6364 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 2 | 2016 | 17446 | 0.040 |
Why?
|
Angiopoietin-2 | 1 | 2018 | 173 | 0.040 |
Why?
|
Male | 7 | 2020 | 350118 | 0.040 |
Why?
|
Genetic Association Studies | 2 | 2016 | 2703 | 0.040 |
Why?
|
Escherichia coli | 1 | 2007 | 4217 | 0.030 |
Why?
|
Signal Transduction | 1 | 2018 | 23403 | 0.030 |
Why?
|
Prognosis | 1 | 2014 | 29063 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2010 | 7880 | 0.030 |
Why?
|
Protein Transport | 2 | 2011 | 1988 | 0.030 |
Why?
|
Biological Transport | 2 | 2007 | 2118 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 13695 | 0.030 |
Why?
|
Genomic Instability | 1 | 2015 | 695 | 0.020 |
Why?
|
Proteomics | 1 | 2023 | 3638 | 0.020 |
Why?
|
Young Adult | 2 | 2016 | 56430 | 0.020 |
Why?
|
Syndrome | 1 | 2016 | 3251 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2016 | 21746 | 0.020 |
Why?
|
Disulfides | 1 | 2010 | 457 | 0.020 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2015 | 1660 | 0.020 |
Why?
|
Transfection | 1 | 2016 | 5892 | 0.020 |
Why?
|
DNA Copy Number Variations | 1 | 2016 | 1941 | 0.020 |
Why?
|
Conserved Sequence | 1 | 2011 | 1202 | 0.020 |
Why?
|
Xenopus laevis | 1 | 2011 | 957 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4204 | 0.020 |
Why?
|
Genetic Complementation Test | 1 | 2007 | 562 | 0.020 |
Why?
|
Hematopoiesis | 1 | 2016 | 2072 | 0.020 |
Why?
|
Cysteine | 1 | 2011 | 874 | 0.020 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2015 | 2455 | 0.020 |
Why?
|
Cell Survival | 1 | 2015 | 5882 | 0.020 |
Why?
|
Cell Membrane Permeability | 1 | 2007 | 590 | 0.020 |
Why?
|
Lipid Bilayers | 1 | 2007 | 381 | 0.020 |
Why?
|
Methionine | 1 | 2007 | 590 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4803 | 0.020 |
Why?
|
Zebrafish | 1 | 2016 | 2994 | 0.020 |
Why?
|
Phosphorylation | 1 | 2015 | 8436 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2727 | 0.010 |
Why?
|
Middle Aged | 2 | 2016 | 213383 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 2007 | 865 | 0.010 |
Why?
|
Drug Resistance | 1 | 2010 | 1609 | 0.010 |
Why?
|
Proto-Oncogene Proteins | 1 | 2015 | 4554 | 0.010 |
Why?
|
Substrate Specificity | 1 | 2007 | 1801 | 0.010 |
Why?
|
Protein Structure, Tertiary | 1 | 2010 | 3846 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2007 | 1526 | 0.010 |
Why?
|
Crystallography, X-Ray | 1 | 2007 | 2011 | 0.010 |
Why?
|
Warfarin | 1 | 2010 | 1496 | 0.010 |
Why?
|
Genotype | 1 | 2015 | 12951 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2016 | 19229 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 16689 | 0.010 |
Why?
|
Cell Line | 1 | 2011 | 15997 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20129 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 63114 | 0.010 |
Why?
|
Child | 1 | 2016 | 77709 | 0.000 |
Why?
|
Adolescent | 1 | 2016 | 85781 | 0.000 |
Why?
|
Adult | 1 | 2016 | 214055 | 0.000 |
Why?
|